Cardiovascular Disease Clinical Trials in Los Angeles, California

3 studies are recruiting for cardiovascular disease in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

    The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in patients with established ASCVD or at high risk for a first ASCVD event. The effect of AZD0780 vs p…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Los Angeles, California
    Locations
    1452 in total
    Run by
    AstraZeneca

    See if you can join NCT07000357 on ClinicalTrials.gov

  2. WISE CVD - Continuation (WISE HFpEF)

    The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 women, has made many contributions to the understanding of cardiovascular disease. A milestone acknowledged in the 2011 AHA Herrick Lecture is the role of Coronary Microvascular Dysfunction (CMD) in women with symptoms/signs …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cedars-Sinai Women's Heart Center, Los Angeles, California
    Run by
    Cedars-Sinai Medical Center

    See if you can join NCT02582021 on ClinicalTrials.gov

  3. OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

    The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp[a]…

    Stage
    Phase 3
    Ages
    50 to 105
    Site
    InvivoCure, Los Angeles, California
    Locations
    252 in total
    Run by
    Amgen

    See if you can join NCT07136012 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.